## An unbiased test for the bioequivalence problem.(English)Zbl 0905.62107

The authors treat the problem demonstrating bioequivalence of treatments. The standard two one-sided tests procedure for bioequivalence is biased, so they construct an unbiased $$\alpha$$-level test. Since, in the construction, the rejection region of the unbiased test contains that of the two one-sided tests procedure, it is seen that the unbiased test is uniformly more powerful than the $$\alpha$$-level two-sided test procedure. The construction is numerically complemented and also the critical region is illustrated.

### MSC:

 62P10 Applications of statistics to biology and medical sciences; meta analysis 62F03 Parametric hypothesis testing
Full Text:

### References:

 [1] Anderson, S. and Hauck, W. W. (1983). A new procedure for testing equivalence in comparative bioavailability and other clinical trials. Comm. Statist. Theory Methods 12 2263-2692. · Zbl 0553.62097 [2] Berger, R. (1982). Multiparameter hy pothesis testing and acceptance sampling. Technometrics 24 295-300. JSTOR: · Zbl 0497.62091 [3] Berger, R. and Hsu, J. (1996). Bioequivalence trials, intersection-union tests and equivalence confidence sets (with discussion). Statist. Sci. 11 283-319. · Zbl 0955.62555 [4] Diletti, E., Hauschke, D. and Steinijans, V. W. (1991). Sample size determination for bioequivalence assessment by means of confidence intervals. International Journal of Clinical Pharmacology, Therapy and Toxicology 29 1-8. [5] EC-GCP (1993). Biostatistical methodology in clinical trials in applications for marketing authorization for medical products. CPMP Working Party on Efficacy of Medical Products, Commission of the European Communities, Brussels. [6] FDA (1992). Draft recommendation on statistical procedures for bioequivalence studies using the standard two-treatment crossover design. Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD. [7] Frick, H. (1987). On level and power of Anderson and Hauck’s procedure for testing equivalence in comparative bioavailability. Comm. Statist. Theory Methods 16 2771-2778. · Zbl 0639.62013 [8] Hauck, W. W. and Anderson, S. (1984). A new statistical procedure for testing equivalence in two-group comparative bioavailability trials. J. Pharmacokinetics and Biopharmaceutics 12 83-91. [9] Hauck, W. W. and Anderson, S. (1996). Comments on ”Bioequivalence trials, intersection-union · Zbl 0988.35147 [10] tests and equivalence confidence sets” by R. Berger and J. Hsu (1996). Statist. Sci. 11 303. [11] Hodges, J. L. and Lehmann, E. L. (1954). Testing the approximate validity of statistical hy pothesis. J. Roy. Statist. Soc. Ser. B 16 261-268. JSTOR: · Zbl 0057.35403 [12] Hsu, J., Hwang, J. T. G., Liu, H. K. and Ruberg, S. J. (1994). Confidence intervals associated with tests for bioequivalence. Biometrika 81 103-114. JSTOR: · Zbl 0803.62094 [13] Hwang, J. T. G. and Liu, H. K. (1992). Confidence intervals associated with tests for bioequivalence. Cornell Statistical Center Technical Report. · Zbl 0803.62094 [14] Lehmann, E. L. (1986). Testing Statistical Hy potheses, 2nd ed. Wiley, New York. [15] Munk, A. (1992). Aquivalenz und Intervalltests in exponentiellen Familien. Ph.D. dissertation, Institut f ür Mathematische Stochastik, Univ. Göttingen. [16] Munk, A. (1993). An improvement on commonly used tests in bioequivalence assessment. Biometrics 49 1225-1230 [see also correspondence in Biometrics 50 884-886 (1994)]. · Zbl 0825.62752 [17] Rocke, D. M. (1984). On testing for bioequivalence. Biometrics 40 225-230 [see also correspondence in Biometrics 41 561-563 (1985)]. JSTOR: · Zbl 0533.62090 [18] Schuirmann, D. J. (1987). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of coverage bioavailability. J. Pharmacokinetics and Biopharmaceutics 15 657-680. [19] Schuirmann, D. J. (1996). Comments on ”Bioequivalence trials, intersection-union tests and equivalence confidence sets” by R. Berger and J. Hsu (1996). Statist. Sci. 11 312-313. [20] Westlake, W. J. (1974). The use of balanced incomplete block designs in comparative bioavailability trials. Biometrics 30 319-327. · Zbl 0285.92009 [21] Westlake, W. J. (1976). Sy mmetrical confidence intervals for bioequivalence trials. Biometrics 32 741-744. · Zbl 0337.62025
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. It attempts to reflect the references listed in the original paper as accurately as possible without claiming the completeness or perfect precision of the matching.